Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2008
10/30/2008US20080269334 Highly Concentrated Pourable Aqueous Solutions Of Potassium Ibuprofen, Their Preparation And Their Use
10/30/2008US20080269325 Methods to Relieve Pain
10/30/2008US20080269323 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphthyl)-propanoate for treating pain and inflammation
10/30/2008US20080269317 Compounds for Covalent Binding to MD-2 and Effect on the Immune Response
10/30/2008US20080269303 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269271 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269239 Antiinflammatory agents; asthma;antiarthritic agents; psoriasis; inflammatory bowel disorders; rhinitis; dermatitis; antiallergens
10/30/2008US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
10/30/2008US20080269225 Prokineticin 1 receptor antagonists
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269209 P 38 map kinase inhibitor; autoimmune diseases; antiinflammatory agents; cardovascular disorders; bone disorders; neurodegenerative diseases; antiproliferative agents
10/30/2008US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders
10/30/2008US20080269189 Method for Avoiding Edema in the Treatment or Prevention of Ppary-Responsive Diseases, Including Cancer
10/30/2008US20080269185 Methods Of Treating Oral Mucositis
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269176 New Salts
10/30/2008US20080269175 Silicone permeated with therapeutic agents; butyl acetate solvent; minocycline, rifampin, clonidine, sulindac; drug-loaded polymeric boots, sheaths, discs; elute drug more rapidly
10/30/2008US20080269129 Polypeptide and dna thereof useful as a neovascular marker
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268081 Method of using guava extract and composition including guava extract
10/30/2008US20080268078 Composition for inhibiting nitric oxide and/or prostaglandin E2 synthesis and method for inhibiting inflammation
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268027 Oral administering a drug; drying self-supporting polymer film and drug dosage
10/30/2008US20080268023 Sufentanil and a bioadhesive material, for sublingual administration
10/30/2008US20080268013 Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267906 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity
10/30/2008US20080267888 Heterocyclic Derivatives
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008CA2721320A1 Boron-containing compounds, uses and preparation thereof
10/30/2008CA2688670A1 Src family kinase inhibitors
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2684701A1 Pyrazoles useful in the treatment of inflammation
10/30/2008CA2684562A1 New use for cannabinoid-containing plant extracts
10/30/2008CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008CA2684003A1 Novel compounds as cannabinoid receptor ligands
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985291A2 Endodontic fibers and methods of use therefor
10/29/2008EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
10/29/2008EP1984377A2 Inhibitors of tnf alpha , pde4 and b-raf, compositions thereof and methods of use therewith
10/29/2008EP1984357A2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
10/29/2008EP1984349A1 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses
10/29/2008EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
10/29/2008EP1984317A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
10/29/2008EP1984028A2 Aqueous pharmaceutical formulations of er selective ligands
10/29/2008EP1983990A1 A3 adenosine receptor allosteric modulators
10/29/2008EP1983986A2 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1861100B1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
10/29/2008EP1778686B1 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
10/29/2008EP1753764B1 Pyrrolopyridine derivatives
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP0831912B2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
10/29/2008CN101296928A Compounds and compositions as protein kinase inhibitors
10/29/2008CN101296924A Pyrazole-isoquinoline urea derivatives as P38 kinase inhibitors
10/29/2008CN101296920A Functionally selective alpha2C adrenoreceptor agonists
10/29/2008CN101296707A Method for prevention and/or treatment of rheumatoid arthritis
10/29/2008CN101293905A Benzoxazole ketone glycoside compounds and preparation method thereof
10/29/2008CN101293894A 2-propylidene-19-nor-vitamin D compounds
10/29/2008CN101293888A Xanthine derivative, production and use thereof as a medicament
10/29/2008CN101293876A Benzoxazole ketones derivative and preparation method thereof
10/29/2008CN101293087A Externally used Chinese medicinal composition for treating orthopedic disorders
10/29/2008CN101293086A Medicament for easing pain and eliminating tumour and preparation method thereof
10/29/2008CN101293052A Traditional Chinese medicine for treating diabetes complications and preparation method thereof
10/29/2008CN101293041A Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis
10/29/2008CN101293033A Combined heating Chinese medicine cotton-padded mattress for treating lumbar diseases
10/29/2008CN101293030A Medicine liqueur for treating muscles and bones diseases
10/29/2008CN101293013A Pharmaceutical composition for treating paralysis, preparation technique and quality testing method
10/29/2008CN101293012A Antiviral honeysuckle flower Chinese medicine compound preparation and preparation technique
10/29/2008CN101293003A Effect section of frangrant ainsliaea herb, preparation method and application thereof
10/29/2008CN101293002A Fingerprint pattern quality control method for cordyceps sinensis bacterium powder raw material in herbs medicaments for strengthening the body resistance and activating blood and dissolving stasis
10/29/2008CN101292975A Application of paclitaxel and its derivative in pharmacy
10/29/2008CN101292952A Glycyrrhizic acid, biogastrone acid or its salt, derivative temperature sensing gel rubber, preparation method and application thereof
10/29/2008CN101292741A Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same
10/29/2008CN100429233C Recombinant solvent protein, its production and use
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429229C Jingzhao toxin V
10/29/2008CN100429228C Recombination human A20 protein and its uses
10/29/2008CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/29/2008CN100428966C Nasal delivery devices
10/29/2008CN100428959C Process for producing drug ultramicroparticle and apparatus therefor
10/29/2008CN100428940C Notoginsenoside pharmaceutical composition and method for preparing the same and use thereof
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 1272